Literature DB >> 12103428

Current research on respiratory viral infections: Fourth International Symposium.

Michael G Ison1, John Mills, Peter Openshaw, Maria Zambon, Albert Osterhaus, Frederick Hayden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12103428      PMCID： PMC7172682          DOI： 10.1016/s0166-3542(02)00055-4

Source DB:  PubMed          Journal:  Antiviral Res        ISSN： 0166-3542            Impact factor:   5.970


× No keyword cloud information.
  198 in total

1.  A defective type 1 response to rhinovirus in atopic asthma.

Authors:  N G Papadopoulos; L A Stanciu; A Papi; S T Holgate; S L Johnston
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

2.  Characterization of the 1918 "Spanish" influenza virus neuraminidase gene.

Authors:  A H Reid; T G Fanning; T A Janczewski; J K Taubenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 3.  Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia.

Authors:  N R Swerdlow; M A Geyer
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

4.  Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

Authors:  K Y Yuen; P K Chan; M Peiris; D N Tsang; T L Que; K F Shortridge; P T Cheung; W K To; E T Ho; R Sung; A F Cheng
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

5.  Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects.

Authors:  Michelle L Seymour; Natalie Gilby; Philip G Bardin; David J Fraenkel; Gwendolyn Sanderson; John F Penrose; Stephen T Holgate; Sebastian L Johnston; Anthony P Sampson
Journal:  J Infect Dis       Date:  2002-01-31       Impact factor: 5.226

Review 6.  To model a psychiatric disorder in animals: schizophrenia as a reality test.

Authors:  B K Lipska; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  2000-09       Impact factor: 7.853

7.  Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care.

Authors:  D A Clements; L Langdon; C Bland; E Walter
Journal:  Arch Pediatr Adolesc Med       Date:  1995-10

8.  A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion.

Authors:  F W Henderson; A M Collier; M A Sanyal; J M Watkins; D L Fairclough; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1982-06-10       Impact factor: 91.245

9.  Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial.

Authors:  S J Sperber; J O Hendley; F G Hayden; D K Riker; J V Sorrentino; J M Gwaltney
Journal:  Ann Intern Med       Date:  1992-07-01       Impact factor: 25.391

10.  Influenza vaccination.

Authors:  M A Riddiough; J E Sisk; J C Bell
Journal:  JAMA       Date:  1983-06-17       Impact factor: 56.272
View more
  12 in total

1.  Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer.

Authors:  Silvana Carr; Natalia A Ilyushina; John Franks; Elisabeth E Adderson; Miguela Caniza; Elena A Govorkova; Robert G Webster
Journal:  Pediatr Infect Dis J       Date:  2011-04       Impact factor: 2.129

Review 2.  Respiratory syncytial virus vaccine development.

Authors:  Yoshihiko Murata
Journal:  Clin Lab Med       Date:  2009-12       Impact factor: 1.935

3.  Current research on respiratory viral infections: Fifth International Symposium.

Authors:  Michael G Ison; Sebastian L Johnston; Peter Openshaw; Brian Murphy; Frederick Hayden
Journal:  Antiviral Res       Date:  2004-06       Impact factor: 5.970

Review 4.  Polyphosphazene immunoadjuvants: Historical perspective and recent advances.

Authors:  Alexander K Andrianov; Robert Langer
Journal:  J Control Release       Date:  2020-12-05       Impact factor: 9.776

Review 5.  Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes.

Authors:  Bradford S Powell; Alexander K Andrianov; Peter C Fusco
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30

6.  A randomized controlled trial of low-dose recombinant human interferons alpha-2b nasal spray to prevent acute viral respiratory infections in military recruits.

Authors:  Lulu Gao; Shouyi Yu; Qing Chen; Zhaojun Duan; Jie Zhou; Chen Mao; Dexian Yu; Wenchang Zhu; Jun Nie; Yunde Hou
Journal:  Vaccine       Date:  2010-04-13       Impact factor: 3.641

7.  Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine.

Authors:  Alexander Marin; Ananda Chowdhury; Sarah M Valencia; Athina Zacharia; Reinhard Kirnbauer; Richard B S Roden; Ligia A Pinto; Robert H Shoemaker; Jason D Marshall; Alexander K Andrianov
Journal:  Nanomedicine       Date:  2021-01-18       Impact factor: 5.307

8.  Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media.

Authors:  Johanna Nokso-Koivisto; Riitta Räty; Soile Blomqvist; Marjaana Kleemola; Ritva Syrjänen; Anne Pitkäranta; Terhi Kilpi; Tapani Hovi
Journal:  J Med Virol       Date:  2004-02       Impact factor: 2.327

Review 9.  Vaccine containing natural TLR ligands protects from Salmonella typhimurium infection in mice and acute respiratory infections in children.

Authors:  Boris Semenov; Vitaly Zverev
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

10.  In Vivo and In Vitro Potency of Polyphosphazene Immunoadjuvants with Hepatitis C Virus Antigen and the Role of Their Supramolecular Assembly.

Authors:  Alexander K Andrianov; Alexander Marin; Ruixue Wang; Ananda Chowdhury; Pragati Agnihotri; Abdul S Yunus; Brian G Pierce; Roy A Mariuzza; Thomas R Fuerst
Journal:  Mol Pharm       Date:  2020-06-23       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.